Literature DB >> 33336932

Risk factors and their diagnostic values for ocular metastases in invasive ductal carcinoma.

Rong-Bin Liang1, Kang Yu1, Jie-Li Wu2, Jia-Xiang Liu1, Qi Lin1, Biao Li1, Yu-Qing Zhang1, Qian-Min Ge1, Qiu-Yu Li1, Hui-Ye Shu1, Yi Shao1.   

Abstract

Invasive ductal carcinoma (IDC) is a major type of breast cancer. Ocular metastasis (OM) in IDC is rarely seen, but patients with OM often have a poor prognosis. Furthermore, OM is difficult to detect in the early stages by common imaging examinations. In the present study, we tried to figure out the risk factors of OM in IDC and evaluate their diagnostic values for early detection. There were 1192 IDC patients who were divided into two groups according to ocular metastasis involved in this study. Clinical parameters of those patients were used to detect differences. The binary logistic regression test was then used to determine the risk factors of OM in IDC. Furthermore, ROC curves of both single and combined risk factors were established to examine their diagnostic values. The incidence of axillary lymph node metastases was significantly higher in the OM group (p = 0.002). Higher carbohydrate antigen 153 (CA153), lower apolipoprotein A1 (ApoA1), and hemoglobin (Hb) were risk factors for OM in IDC (p < 0.001, p < 0.001, p = 0.038, respectively). In the single risk factor ROC analysis, cutoff values of CA153, ApoA1, and Hb were 43.3 u/mL (CI: 0.966-0.984, p < 0.001), 1.11 g/L (CI: 0.923-0.951, p < 0.001), and 112 g/L (CI: 0.815-0.857, p < 0.001), respectively. Among the ROC curves of combined risk factors, CA153+ApoA1+Hb had the best accuracy, with the sensitivity and specificity of 89.47% and 99.32%, respectively (CI: 0.964-0.983, p < 0.001). CA153, ApoA1, and Hb are risk factors for OM in IDC. In clinical practice, the three parameters could be used as predictive factors for the early detection of OM.
© 2020 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.

Entities:  

Keywords:  HIF-1; diagnostic value; invasive ductal cancer; ocular metastasis; risk factors

Mesh:

Substances:

Year:  2020        PMID: 33336932      PMCID: PMC7897965          DOI: 10.1002/cam4.3656

Source DB:  PubMed          Journal:  Cancer Med        ISSN: 2045-7634            Impact factor:   4.452


  31 in total

Review 1.  Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B/AI ratio and coronary heart disease: a literature-based meta-analysis of prospective studies.

Authors:  A Thompson; J Danesh
Journal:  J Intern Med       Date:  2006-05       Impact factor: 8.989

2.  Use of CA15-3, CEA and prolactin for the primary diagnosis of breast cancer and correlation with the prognostic factors at the time of initial diagnosis.

Authors:  N Arslan; M Serdar; S Deveci; B Ozturk; Y Narin; S Ilgan; E Ozturk; M A Ozguven
Journal:  Ann Nucl Med       Date:  2000-10       Impact factor: 2.668

3.  Prognostic impact of total tumor volume and hemoglobin concentration on the outcome of patients with advanced head and neck cancer after concomitant boost radiochemotherapy.

Authors:  V Rudat; A Dietz; O Schramm; C Conradt; H Maier; M Flentje; M Wannenmacher
Journal:  Radiother Oncol       Date:  1999-11       Impact factor: 6.280

4.  Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition.

Authors:  Fränzel J B van Duijnhoven; H Bas Bueno-De-Mesquita; Miriam Calligaro; Mazda Jenab; Tobias Pischon; Eugène H J M Jansen; Jiri Frohlich; Amir Ayyobi; Kim Overvad; Anne Pernille Toft-Petersen; Anne Tjønneland; Louise Hansen; Marie-Christine Boutron-Ruault; Françoise Clavel-Chapelon; Vanessa Cottet; Domenico Palli; Giovanna Tagliabue; Salvatore Panico; Rosario Tumino; Paolo Vineis; Rudolf Kaaks; Birgit Teucher; Heiner Boeing; Dagmar Drogan; Antonia Trichopoulou; Pagona Lagiou; Vardis Dilis; Petra H M Peeters; Peter D Siersema; Laudina Rodríguez; Carlos A González; Esther Molina-Montes; Miren Dorronsoro; Maria-Jose Tormo; Aurelio Barricarte; Richard Palmqvist; Göran Hallmans; Kay-Tee Khaw; Kostas K Tsilidis; Francesca L Crowe; Veronique Chajes; Veronika Fedirko; Sabina Rinaldi; Teresa Norat; Elio Riboli
Journal:  Gut       Date:  2011-03-07       Impact factor: 23.059

Review 5.  Response of tumour cells to hypoxia: role of p53 and NFkB.

Authors:  J A Royds; S K Dower; E E Qwarnstrom; C E Lewis
Journal:  Mol Pathol       Date:  1998-04

Review 6.  Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability.

Authors:  Robert G Bristow; Richard P Hill
Journal:  Nat Rev Cancer       Date:  2008-03       Impact factor: 60.716

7.  Hemoglobin level predicts outcome for vulvar cancer patients independent of GLUT-1 and CA-IX expression in tumor tissue.

Authors:  Hedwig P van de Nieuwenhof; Joanne A de Hullu; Johannes H A M Kaanders; Johan Bulten; Leon F A G Massuger; Léon C L T van Kempen
Journal:  Virchows Arch       Date:  2010-10-02       Impact factor: 4.064

8.  The risk factors of bone metastases in patients with lung cancer.

Authors:  Yang Zhou; Qing-Fu Yu; Ai-Fen Peng; Wei-Lai Tong; Jia-Ming Liu; Zhi-Li Liu
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.379

9.  Serological diagnosis of liver metastasis in patients with breast cancer.

Authors:  Rui Cao; Li-Ping Wang
Journal:  Cancer Biol Med       Date:  2012-03       Impact factor: 4.248

10.  Serum calcium, alkaline phosphotase and hemoglobin as risk factors for bone metastases in bladder cancer.

Authors:  Ping Huang; Min Lan; Ai-Fen Peng; Qing-Fu Yu; Wen-Zhao Chen; Zhi-Li Liu; Jia-Ming Liu; Shan-Hu Huang
Journal:  PLoS One       Date:  2017-09-13       Impact factor: 3.240

View more
  1 in total

1.  Clinicopathological Features of 166 Cases of Invasive Ductal Breast Carcinoma and Effect of Primary Tumor Location on Prognosis after Modified Radical Mastectomy.

Authors:  Shiman Chen; Liang Yang; Yaqiong Li
Journal:  Emerg Med Int       Date:  2022-06-18       Impact factor: 1.621

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.